MCM
NVO

MAI Capital Management’s Novo Nordisk NVO Stock Holding History

MAI Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$517K – 1249
2023
Q4 		$517K Buy
+5,000
New +$494K 0.01% 693

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

MAI Capital Management's NVO Position: Q1 2026 in Review

MAI Capital Management increased its Novo Nordisk (NVO) stake by 4.5% in Q1 2026, buying an estimated $91.8K and bringing the position to 44,633 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #630.

MAI Capital Management first reported a position in NVO in Q2 2019 and has held it in 28 quarters since. The position peaked at $6.95M in Q2 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • MAI Capital Management held 44,633 shares of Novo Nordisk worth $1.64M as of Q1 2026.
  • MAI Capital Management bought 1,937 Novo Nordisk shares in Q1 2026, an estimated $91.8K.
  • Novo Nordisk made up 0.01% of MAI Capital Management's portfolio in Q1 2026, its #630 holding.
  • MAI Capital Management first reported a position in Novo Nordisk in Q2 2019 and has held it in 28 quarters since.
  • MAI Capital Management's Novo Nordisk position peaked at $6.95M in Q2 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.